InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Honore Tage. Director active across 1 company, notably Vanda Pharmaceuticals Inc.. Aggregated, 5 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €204k. History available since 15 March 2023. The latest transaction was filed on 23 February 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Honore Tage is a declarant linked to Vanda Pharmaceuticals Inc., where the listed role is Director. Across 5 filings in total, the 5 sampled filings run from 2023-03-17 to 2026-02-24, with 0 in buys and 203553 in sells, and the modal transaction nature is Attribution.